See more : Artesian Resources Corporation (ARTNB) Income Statement Analysis – Financial Results
Complete financial analysis of Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Jiangxi Synergy Pharmaceutical Co., Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Silver Spruce Resources Inc. (SSEBF) Income Statement Analysis – Financial Results
- Dolby Laboratories, Inc. (DLB) Income Statement Analysis – Financial Results
- Lam Research Corporation (0JT5.L) Income Statement Analysis – Financial Results
- Sebang Co., Ltd (004360.KS) Income Statement Analysis – Financial Results
- Auras Technology Co., Ltd. (3324.TWO) Income Statement Analysis – Financial Results
Jiangxi Synergy Pharmaceutical Co., Ltd. (300636.SZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.jxsynergy.com
About Jiangxi Synergy Pharmaceutical Co., Ltd.
Jiangxi Synergy Pharmaceutical Co., Ltd. manufactures and sells APIs worldwide. It offers APIs, liquid crystal compounds, and intermediates. Jiangxi Synergy Pharmaceutical Co., Ltd. was founded in 2004 and is headquartered in Yichun, the People's Republic of China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 722.14M | 719.91M | 592.13M | 435.42M | 413.06M | 267.12M | 296.72M | 250.08M | 274.81M | 212.57M | 141.56M | 104.62M |
| Cost of Revenue | 501.78M | 486.45M | 413.27M | 283.27M | 290.20M | 188.94M | 188.13M | 153.26M | 165.55M | 129.79M | 91.91M | 72.44M |
| Gross Profit | 220.36M | 233.45M | 178.85M | 152.15M | 122.85M | 78.19M | 108.59M | 96.81M | 109.26M | 82.79M | 49.65M | 32.18M |
| Gross Profit Ratio | 30.51% | 32.43% | 30.21% | 34.94% | 29.74% | 29.27% | 36.60% | 38.71% | 39.76% | 38.94% | 35.07% | 30.76% |
| Research & Development | 63.15M | 60.91M | 39.02M | 35.30M | 36.33M | 25.36M | 12.52M | 12.74M | 14.36M | 9.40M | 7.05M | 6.57M |
| General & Administrative | 7.02M | 4.79M | 5.42M | 3.80M | 5.37M | 13.44M | 4.29M | 3.76M | 5.79M | 3.85M | 17.01M | 15.16M |
| Selling & Marketing | 26.26M | 18.47M | 18.03M | 13.85M | 13.07M | 11.36M | 9.47M | 10.41M | 10.39M | 9.48M | 8.05M | 5.95M |
| SG&A | 32.14M | 23.26M | 23.44M | 17.65M | 18.45M | 24.80M | 13.76M | 14.17M | 16.18M | 13.33M | 25.07M | 21.11M |
| Other Expenses | 268.09K | 25.09M | 17.10M | 9.80M | 7.02M | 43.80K | 1.84M | 9.30M | 6.73M | 3.83M | 3.54M | 3.33M |
| Operating Expenses | 115.54M | 109.26M | 79.57M | 62.75M | 61.80M | 55.77M | 35.26M | 38.31M | 41.71M | 32.06M | 25.75M | 21.42M |
| Cost & Expenses | 617.32M | 595.72M | 492.84M | 346.02M | 352.00M | 244.71M | 223.39M | 191.58M | 207.26M | 161.84M | 117.66M | 93.86M |
| Interest Income | 17.01M | 2.89M | 1.95M | 568.73K | 161.27K | 94.59K | 327.84K | 184.66K | 175.32K | 35.26K | 5.93M | 3.93M |
| Interest Expense | 10.65M | 7.70M | 5.69M | 8.99M | 4.21M | 1.63K | 521.39K | 1.70M | 4.57M | 7.88M | 0.00 | 0.00 |
| Depreciation & Amortization | 69.39M | 66.88M | 51.58M | 52.33M | 42.77M | 23.86M | 20.77M | 2.91M | 15.27M | 12.61M | 7.90M | 5.32M |
| EBITDA | 192.54M | 181.48M | 146.08M | 139.72M | 99.06M | 50.19M | 96.24M | 72.72M | 80.84M | 65.95M | 23.90M | 10.76M |
| EBITDA Ratio | 26.66% | 26.39% | 25.88% | 32.27% | 25.43% | 19.89% | 32.72% | 35.76% | 33.63% | 31.42% | 16.86% | 10.57% |
| Operating Income | 112.23M | 106.33M | 88.34M | 78.25M | 51.68M | 26.28M | 72.76M | 58.39M | 65.85M | 41.63M | 15.97M | 5.73M |
| Operating Income Ratio | 15.54% | 14.77% | 14.92% | 17.97% | 12.51% | 9.84% | 24.52% | 23.35% | 23.96% | 19.59% | 11.28% | 5.48% |
| Total Other Income/Expenses | 268.09K | -182.74K | 1.00 | -6.73M | -3.83M | 14.54M | 1.84M | 9.12M | 6.73M | -4.42M | -4.42M | 3.17M |
| Income Before Tax | 112.50M | 106.15M | 88.34M | 78.06M | 51.68M | 26.33M | 74.60M | 67.51M | 72.58M | 45.46M | 19.51M | 8.90M |
| Income Before Tax Ratio | 15.58% | 14.74% | 14.92% | 17.93% | 12.51% | 9.86% | 25.14% | 27.00% | 26.41% | 21.39% | 13.78% | 8.50% |
| Income Tax Expense | 6.52M | 5.48M | 7.22M | 8.01M | 3.37M | 1.79M | 9.15M | 9.52M | 9.70M | 6.25M | 2.62M | 869.20K |
| Net Income | 105.98M | 100.67M | 81.12M | 70.05M | 48.31M | 24.53M | 65.46M | 58.00M | 62.88M | 39.21M | 16.88M | 8.03M |
| Net Income Ratio | 14.68% | 13.98% | 13.70% | 16.09% | 11.70% | 9.18% | 22.06% | 23.19% | 22.88% | 18.44% | 11.93% | 7.67% |
| EPS | 0.28 | 0.31 | 0.26 | 0.23 | 0.16 | 0.08 | 0.23 | 0.25 | 0.29 | 0.32 | 0.14 | 0.05 |
| EPS Diluted | 0.28 | 0.29 | 0.24 | 0.23 | 0.16 | 0.08 | 0.22 | 0.25 | 0.29 | 0.32 | 0.14 | 0.05 |
| Weighted Avg Shares Out | 380.36M | 326.43M | 308.75M | 309.39M | 308.69M | 308.95M | 289.32M | 230.40M | 219.47M | 146.34M | 146.34M | 146.34M |
| Weighted Avg Shares Out (Dil) | 380.39M | 346.18M | 337.62M | 309.56M | 311.57M | 312.33M | 291.13M | 230.40M | 219.51M | 146.34M | 146.34M | 146.34M |
Source: https://incomestatements.info
Category: Stock Reports